Literature DB >> 28028839

Streptococcus pneumoniae IgA1 protease: A metalloprotease that can catalyze in a split manner in vitro.

Ying-Chih Chi1, Jeremy T Rahkola2,3, Agnieszka A Kendrick1, Michael J Holliday1, Natasia Paukovich1, Thomas S Roberts1, Edward N Janoff2,3, Elan Z Eisenmesser1.   

Abstract

IgA1 proteases (IgA1P) from diverse pathogenic bacteria specifically cleave human immunoglobulin A1 (IgA1) at the hinge region, thereby thwarting protective host immune responses. Streptococcus pneumoniae (S. pneumoniae) IgA1P shares no sequence conservation with serine or cysteine types of IgA1Ps or other known proteins, other than a conserved HExxH Zn-binding motif (1604-1608) found in metalloproteases. We have developed a novel expression system to produce the mature S. pneumoniae IgA1P and we have discovered that this form is both attached to the bacterial cell surface and released in its full form. Our data demonstrate that the S. pneumoniae IgA1P comprises two distinct regions that associate to form an active metalloprotease, the first such example of a metalloprotease that can be split in vitro and recombined to form an active enzyme. By capitalizing on this novel domain architecture, we show that the N-terminal region of S. pneumoniae IgA1P comprises the primary binding region for IgA1, although the C-terminal region of S. pneumoniae IgA1P is necessary for cleavage of IgA1. Our findings lend insight into the protein domain architecture of the S. pneumoniae IgA1P and function of this important virulence factor for S. pneumoniae infection.
© 2016 The Protein Society.

Entities:  

Keywords:  IgA1 protease; metalloprotease; protease turnover; split protease; streptococcal pneumoniae

Mesh:

Substances:

Year:  2017        PMID: 28028839      PMCID: PMC5326571          DOI: 10.1002/pro.3110

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  28 in total

1.  Cloning, expression, purification, and characterization of Streptococcus pneumoniae IgA1 protease.

Authors:  V Romanello; M Marcacci; F Dal Molin; M Moschioni; S Censini; A Covacci; A G Baritussio; C Montecucco; F Tonello
Journal:  Protein Expr Purif       Date:  2005-08-11       Impact factor: 1.650

Review 2.  The thermolysin family (M4) of enzymes: therapeutic and biotechnological potential.

Authors:  Olayiwola A Adekoya; Ingebrigt Sylte
Journal:  Chem Biol Drug Des       Date:  2009-01       Impact factor: 2.817

3.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

4.  The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.

Authors:  Deborah Lehmann; Judith Willis; Hannah C Moore; Carolien Giele; Denise Murphy; Anthony D Keil; Catherine Harrison; Kathy Bayley; Michael Watson; Peter Richmond
Journal:  Clin Infect Dis       Date:  2010-06-01       Impact factor: 9.079

Review 5.  Burden of community-acquired pneumonia in North American adults.

Authors:  Thomas M File; Thomas J Marrie
Journal:  Postgrad Med       Date:  2010-03       Impact factor: 3.840

6.  Neisseria gonorrhoeae and neisseria meningitidis: extracellular enzyme cleaves human immunoglobulin A.

Authors:  A G Plaut; J V Gilbert; M S Artenstein; J D Capra
Journal:  Science       Date:  1975-12-12       Impact factor: 47.728

Review 7.  Streptococcus pneumoniae--a review of carriage, infection, serotype replacement and vaccination.

Authors:  Sam Mehr; Nicholas Wood
Journal:  Paediatr Respir Rev       Date:  2012-01-18       Impact factor: 2.726

8.  Pneumococcal IgA1 protease subverts specific protection by human IgA1.

Authors:  E N Janoff; J B Rubins; C Fasching; D Charboneau; J T Rahkola; A G Plaut; J N Weiser
Journal:  Mucosal Immunol       Date:  2013-07-03       Impact factor: 7.313

9.  Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin A.

Authors:  Jennifer Schlegel; Jasmina S Redzic; Christopher C Porter; Vyacheslav Yurchenko; Michael Bukrinsky; Wladimir Labeikovsky; Geoffrey S Armstrong; Fengli Zhang; Nancy G Isern; James DeGregori; Robert Hodges; Elan Zohar Eisenmesser
Journal:  J Mol Biol       Date:  2009-06-03       Impact factor: 5.469

10.  Antibody blocks acquisition of bacterial colonization through agglutination.

Authors:  A M Roche; A L Richard; J T Rahkola; E N Janoff; J N Weiser
Journal:  Mucosal Immunol       Date:  2014-06-25       Impact factor: 7.313

View more
  6 in total

1.  Small-Molecule Inhibitors of Haemophilus influenzae IgA1 Protease.

Authors:  Livia Shehaj; Santosh K Choudary; Kamlesh M Makwana; Mary C Gallo; Timothy F Murphy; Joshua A Kritzer
Journal:  ACS Infect Dis       Date:  2019-05-03       Impact factor: 5.084

2.  Immunoglobulin A Glycosylation and Its Role in Disease.

Authors:  Alyssa L Hansen; Colin Reily; Jan Novak; Matthew B Renfrow
Journal:  Exp Suppl       Date:  2021

Review 3.  More than a Pore: Nonlytic Antimicrobial Functions of Complement and Bacterial Strategies for Evasion.

Authors:  Elisabet Bjanes; Victor Nizet
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-27       Impact factor: 11.056

Review 4.  Streptococcus pneumoniae's Virulence and Host Immunity: Aging, Diagnostics, and Prevention.

Authors:  Lavida R K Brooks; George I Mias
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

5.  Pathogenicity and virulence of Streptococcus pneumoniae: Cutting to the chase on proteases.

Authors:  Mary E Marquart
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

6.  Mechanism and inhibition of Streptococcus pneumoniae IgA1 protease.

Authors:  Zhiming Wang; Jeremy Rahkola; Jasmina S Redzic; Ying-Chih Chi; Norman Tran; Todd Holyoak; Hongjin Zheng; Edward Janoff; Elan Eisenmesser
Journal:  Nat Commun       Date:  2020-11-27       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.